IJSER Home >> Journal >> IJSER
International Journal of Scientific and Engineering Research
ISSN Online 2229-5518
ISSN Print: 2229-5518 2    
Website: http://www.ijser.org
scirp IJSER >> Volume 3,Issue 2,February 2012
Application of IT in Biomedical Field: Present Status and Future Prospects
Full Text(PDF, )  PP.169-174  
Author(s)
Dr. Leena Jain, Dr. Kawaljeet Singh
KEYWORDS
— Biomedical, IT, Application, Pharmaceutical, Research, Software
ABSTRACT
In the knowledge economy, information has become the most important resource allowing both firms and nations to grow. For every drug that reaches the market, there are more than I0,000 compounds synthesized, characterized, and tested for biological effects if we go by conventional laboratory procedure. This process takes place in about 12 years. But this task of drug discovery and evaluation is going to carry out at much faster rate and at significantly lower cost with the use of computer based program's. called software. Not only pharmaceutical, biotechnological and biomedical research required software but production, automation of process and its control, clinical diagnosis of disease and clinical trials of anti-AIDS and cancer drug all required some sophisticated software. Overall without use of software there is no simple task is possible in biomedical research. Today, computers are so important in biomedical research and development that it may be hard to imagine a time when there were no computers to assist the researchers. In this article we summarized the use of software in different aspects of biomedical research.
References
[1] Di Masi JA. et al. (2003) ‚The price of innovation: new estimates of drug development costs‛, J Health Econ, Vol 22, pp. 151–185.

[2] Englebienne P (2005) ‚High throughput screening: will the past meet the future?‛, Frontiers Drug Design Discov, Vol. 1, pp. 69–86.

[3] Wolohan PR. et al. (2003) ‚Predicting drug pharmacokinetic properties using to meet the challenges in ADME and e-ADME?‛, J Comput Aided Mol Des, Vol. 17, pp 65–76.

[4] Ertle P. et al. (2003) ‚Web-based cheminformatics and molecular property prediction tools supporting drug design and development at novartis‛, SAR QSAR Environ Res, Vol. 14, pp. 321–328.

[5] Ertle P. et al. (2004) ‚Web-based cheminformatics tools deployed via corporate Intranets‛, Drug Discov Today Biosilico, Vol. 2. pp 201–207.

[6] Geysen HM. et al. (2003) ‚Combinatorial compound libraries for drug discovery: an ongoing challenge‛, Nat Rev Drug Discov, Vol. 2, pp 222–230.

[7] Brown FK (1998) ‚Cheminformatics: What is it and how does it impact drug discovery‛, Ann Rep Med Chem, Vol. 33, pp. 375–384.

[8] Tetko IV, (2003) ‚The www as a tool to obtain molecular parameters‛ Mini Rev Med Chem, Vol. 3, pp. 809–820.

[9] Tetko IV (2005) ‚Computing chemistry on the Web. Drug Delivery and Technology‛, Vol. 22, pp.1497-1500.

[10]Tetko IV. and Tanchuk VY (2002) ‚Application of associative neural networks for prediction of lipophilicity in ALOGPS 2.1 program‛, J Chem Inf Comput Sci, Vol. 42, pp 1136–1145

[11] Sirkka-Liisa and Jamsa-Jounela (2007) ‚Future trends in process automation‛, Annual Reviews in Control, Vol. 31, pp 211– 220.

[12]Mansa RF, Bridson RH, Greenwood RW, Barker H, Seville JPK (2008) ‚Using intelligent software to predict the effects of formulation and processing parameters on roller compaction‛, Powder Technology, Vol. 181, pp 217-225.

[13] Stein L. (2002) ‚Creating a bioinformatics nation‛, Nature, Vol. 417, pp 119–120.

[14]Miller AB. et al. (1981) ‚Reporting results of cancer treatment‛, Cancer, Vol.74, pp 207–214

[15] Paty DW and Li DK (1993) ‚Interferon beta- 1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial‛, Neurology, Vol 43, pp 662–667.

[16] Peterfy CG (1994) ‚Quantification of articular cartilage in the knee with pulsed saturation transfer subtraction and fat-suppressed MR imaging: optimization and validation‛, Radiology, Vol. 192, pp 485–491.

[17] Peterfy CG (2001) ‚Role of MR imaging in clinical research studies‛, Semin Musculoskelet Radiol, Vol. 5, pp 365–378.

[18] Cohen ZA. et al. (1999) ‚Knee cartilage topography, thickness, and contact areas from MRI: in-vitro calibration and in-vivo measurements‛ Osteoarthritis Cartilage, Vol 7, pp 95–109

[19] Wluka AE. et al. (2002) ‚The determinants of change in tibial cartilage volume in osteoarthritic knees‛, Arthritis Rheum, Vol. 46, pp 2065–2072.

[20] Pham DL. et al. (2000) ‚Current methods in medical image segmentation‛, Annu Rev Biomed Eng, Vol. 2, pp 315–337.

[21] Smith SM. et al. (2002) ‚Accurate, robust, and automated longitudinal and cross-sectional brain change analysis‛, Neuroimage, Vol. 17, pp 479–489.

[22]Almeida-Prieto S, Blanco-Me´ndez J, OteroEspinar FJ (2007) ‚Microscopic image analysis techniques for the morphological characterization of pharmaceutical particles: Influence of the software, and the factor algorithms used in the shape factor estimation‛, Eur J Pharm Biopharm, Vol. 67, pp. 766–776

Untitled Page